Bank of New York Mellon Corp - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 94 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2015. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$36,763,372
+46.4%
4,402,799
+133.2%
0.01%
+60.0%
Q2 2023$25,112,297
+45.1%
1,888,143
+26.3%
0.01%
+25.0%
Q1 2023$17,311,007
+119.5%
1,494,906
+55.1%
0.00%
+100.0%
Q4 2022$7,885,864
+41.1%
964,042
+0.2%
0.00%
+100.0%
Q3 2022$5,587,000
+49.2%
962,390
+13.6%
0.00%0.0%
Q2 2022$3,745,000
-58.7%
847,232
-15.0%
0.00%
-50.0%
Q1 2022$9,074,000
-55.9%
997,044
-1.0%
0.00%
-50.0%
Q4 2021$20,597,000
-19.0%
1,006,739
+1.2%
0.00%
-20.0%
Q3 2021$25,423,000
-23.8%
995,019
+4.3%
0.01%
-16.7%
Q2 2021$33,354,000
+4.0%
953,789
-1.0%
0.01%
-14.3%
Q1 2021$32,079,000
+23.0%
963,031
-4.2%
0.01%
+16.7%
Q4 2020$26,070,000
+158.2%
1,005,020
-1.7%
0.01%
+200.0%
Q3 2020$10,095,000
+186.5%
1,022,858
+0.1%
0.00%
+100.0%
Q2 2020$3,524,000
+7.7%
1,021,563
-4.5%
0.00%0.0%
Q1 2020$3,271,000
-40.4%
1,069,174
+0.1%
0.00%0.0%
Q4 2019$5,491,000
-4.0%
1,068,316
-3.6%
0.00%
-50.0%
Q3 2019$5,720,000
+44.5%
1,108,384
+69.5%
0.00%
+100.0%
Q2 2019$3,958,000
-14.7%
654,103
+1.9%
0.00%0.0%
Q1 2019$4,642,000
+1.1%
642,089
+3.5%
0.00%0.0%
Q4 2018$4,590,000
+55.3%
620,301
+13.5%
0.00%0.0%
Q3 2018$2,955,000
+70.6%
546,299
+12.0%
0.00%
Q2 2018$1,732,000
+93.1%
487,890
+11.6%
0.00%
Q1 2018$897,000
-18.8%
437,191
+4.5%
0.00%
Q4 2017$1,105,000
-54.2%
418,406
-9.0%
0.00%
-100.0%
Q3 2017$2,412,000
+81.6%
459,558
+23.2%
0.00%
Q2 2017$1,328,000
-37.0%
373,143
-8.5%
0.00%
-100.0%
Q1 2017$2,108,000
+42.2%
407,898
+4.6%
0.00%
Q4 2016$1,482,000
-54.7%
390,104
+6.9%
0.00%
-100.0%
Q3 2016$3,270,000
+29.5%
364,905
+1.7%
0.00%0.0%
Q2 2016$2,525,000
-10.6%
358,890
+8.1%
0.00%0.0%
Q1 2016$2,823,000
-33.2%
332,067
+3.2%
0.00%0.0%
Q4 2015$4,226,000
+245.8%
321,888
-3.7%
0.00%
Q3 2015$1,222,000
-45.8%
334,105
-14.6%
0.00%
-100.0%
Q2 2015$2,254,000
+10.0%
391,384
+11.5%
0.00%0.0%
Q1 2015$2,049,000
-21.2%
350,924
+5.9%
0.00%0.0%
Q4 2014$2,599,000
+85.2%
331,500
+16.0%
0.00%
Q3 2014$1,403,000
-60.1%
285,823
-49.7%
0.00%
Q2 2014$3,514,000
+200.1%
568,424
+159.7%
0.00%
Q1 2014$1,171,000
-4.3%
218,881
-6.5%
0.00%
Q4 2013$1,224,000
-49.1%
234,028
-46.3%
0.00%
Q3 2013$2,406,000
+334.3%
435,830
+99.2%
0.00%
Q2 2013$554,000218,8040.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q1 2015
NameSharesValueWeighting ↓
Madrone Advisors, LLC 16,415,933$137,073,04129.47%
ORACLE INVESTMENT MANAGEMENT INC 1,638,395$13,680,5984.20%
Decheng Capital Management III (Cayman), LLC 1,463,872$12,223,3314.08%
VK Services, LLC 2,632,784$21,983,7462.93%
Iron Triangle Partners LP 1,800,000$15,030,0002.20%
BOURNE LENT ASSET MANAGEMENT INC 574,350$4,795,8222.11%
Deep Track Capital, LP 6,000,000$50,100,0001.93%
Jackson Square Partners, LLC 6,933,865$57,897,7731.93%
ARK Investment Management 29,822,440$249,017,3701.90%
Nikko Asset Management Americas, Inc. 13,447,666$112,153,5341.34%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders